Chapter
Abbreviations
pp.：
47 – 49
Side Effects of Drugs Essay: An agenda for research into adverse drug reactions
pp.：
49 – 54
Chapter 1: Central nervous system stimulants and drugs that suppress appetite
pp.：
54 – 70
Chapter 2: Antidepressant drugs
pp.：
70 – 78
Chapter 3: Lithium
pp.：
78 – 86
Chapter 4: Drugs of abuse
pp.：
86 – 98
Chapter 5: Hypnosedatives and anxiolytics
pp.：
98 – 104
Chapter 6: Antipsychotic drugs
pp.：
104 – 138
Chapter 7: Antiepileptic drugs
pp.：
138 – 198
Chapter 8: Opioid analgesics and narcotic antagonists
pp.：
198 – 234
Chapter 9: Anti-inflammatory and antipyretic analgesics and drugs used in gout
pp.：
234 – 248
Chapter 10: General anesthetics and therapeutic gases
pp.：
248 – 262
Chapter 11: Local anesthetics
pp.：
262 – 274
Chapter 12: Neuromuscular blocking agents and skeletal muscle relaxants
pp.：
274 – 286
Chapter 13: Drugs that affect autonomic functions or the extrapyramidal system
pp.：
286 – 310
Chapter 14: Dermatological drugs, topical agents, and cosmetics
pp.：
310 – 324
Chapter 15: Antihistamines (H1 receptor antagonists)
pp.：
324 – 330
Chapter 16: Drugs that act on the respiratory tract
pp.：
330 – 340
Chapter 17: Positive inotropic drugs and drugs used in dysrhythmias
pp.：
340 – 356
Chapter 18: Beta-adrenoceptor antagonists and antianginal drugs
pp.：
356 – 364
Chapter 19: Drugs acting on the cerebral and peripheral circulations
pp.：
364 – 370
Chapter 20: Antihypertensive drugs
pp.：
370 – 392
Chapter 21: Diuretics
pp.：
392 – 402
Chapter 22: Metals
pp.：
402 – 420
Chapter 23: Metal antagonists
pp.：
420 – 430
Chapter 24: Antiseptic drugs and disinfectants
pp.：
430 – 438
Chapter 25: Penicillins, cephalosporins, other beta-lactam antibiotics, and tetracyclines
pp.：
438 – 452
Chapter 26: Miscellaneous antibacterial drugs
pp.：
452 – 480
Chapter 27: Antifungal drugs
pp.：
480 – 494
Chapter 28: Antiprotozoal drugs
pp.：
494 – 500
Chapter 29: Antiviral drugs
pp.：
500 – 532
Chapter 30: Drugs used in tuberculosis and leprosy
pp.：
532 – 540
Chapter 31: Antihelminthic drugs
pp.：
540 – 552
Chapter 32: Vaccines
pp.：
552 – 562
Chapter 33: Blood, blood components, plasma, and plasma products
pp.：
562 – 584
Chapter 34: Vitamins, intravenous solutions, and drugs and formulations used in nutrition
pp.：
584 – 594
Chapter 35: Drugs that affect blood coagulation, fibrinolysis, and hemostasis
pp.：
594 – 608
Chapter 36: Gastrointestinal drugs
pp.：
608 – 632
Chapter 37: Drugs that act on the immune system: cytokines and monoclonal antibodies
pp.：
632 – 662
Chapter 38: Drugs that act on the immune system: immunosuppressive and immunostimulatory drugs
pp.：
662 – 706
Chapter 39: Corticotrophins, corticosteroids, and prostaglandins
pp.：
706 – 716
Chapter 40: Sex hormones and related compounds, including hormonal contraceptives
pp.：
716 – 732
Chapter 41: Thyroid hormones, iodine, and antithyroid drugs
pp.：
732 – 738
Chapter 42: Insulin, other hypoglycemic drugs, and glucagon
pp.：
738 – 756
Chapter 43: Miscellaneous hormones
pp.：
756 – 776
Chapter 44: Drugs that affect lipid metabolism
pp.：
776 – 784
Chapter 45: Cytostatic and cytotoxic drugs
pp.：
784 – 802
Chapter 46: Radiological contrast agents and radiopharmaceuticals
pp.：
802 – 814
Chapter 47: Drugs used in ocular treatment
pp.：
814 – 822
Chapter 48: Treatments used in complementary and alternative medicine
pp.：
822 – 838
Chapter 49: Miscellaneous drugs, materials, medical devices, and techniques
pp.：
838 – 854
Index of drugs
pp.：
854 – 876
Index of drug-drug interactions
pp.：
876 – 880
Index of adverse effects and adverse reactions
pp.：
880 – 902
Side Effects of Drugs Annual
：A worldwide yearly survey of new data in adverse drug reactions
( Volume 34 )
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
